117 related articles for article (PubMed ID: 14556784)
1. Synthesis and evaluation of alpha,alpha-disubstituted-3-mercaptopropanoic acids as inhibitors for carboxypeptidase A and implications with respect to enzyme inhibitor design.
Lee HS; Kim DH
Bioorg Med Chem; 2003 Nov; 11(22):4685-91. PubMed ID: 14556784
[TBL] [Abstract][Full Text] [Related]
2. Optically active 2-benzyl-3-methanesulfinylpropanoic acid: Synthesis and evaluation as inhibitors for carboxypeptidase A.
Jin JY; Tian GR; Kim DH
Bioorg Med Chem; 2003 Oct; 11(20):4377-81. PubMed ID: 13129575
[TBL] [Abstract][Full Text] [Related]
3. 2-Benzyl-2-methylsuccinic acid as inhibitor for carboxypeptidase A. synthesis and evaluation.
Lee M; Jin Y; Kim DH
Bioorg Med Chem; 1999 Aug; 7(8):1755-60. PubMed ID: 10482467
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and kinetic evaluation of racemic and optically active 2-benzyl-2-methyl-3,4-epoxybutanoic acids as irreversible inactivators for carboxypeptidase A.
Lee M; Kim DH
Bioorg Med Chem; 2002 Apr; 10(4):913-22. PubMed ID: 11836098
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of (1-(D-2-hydroxy-3-mercaptopropanoic acid))oxytocin, a diastereoisomer of the hydroxy-isostere of oxytocin.
Wälti M; Hope DB
J Chem Soc Perkin 1; 1974; 2():202-5. PubMed ID: 4856211
[No Abstract] [Full Text] [Related]
6. Nitro as a novel zinc-binding group in the inhibition of carboxypeptidase A.
Wang SH; Wang SF; Xuan W; Zeng ZH; Jin JY; Ma J; Tian GR
Bioorg Med Chem; 2008 Apr; 16(7):3596-601. PubMed ID: 18289863
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of (1-(L-2-hydroxy-3-mercaptopropanoic acid))oxytocin, a highly potent analogue of oxytocin.
Wälti M; Hope DB
J Chem Soc Perkin 1; 1972; 15():1946-50. PubMed ID: 4672381
[No Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of thiol-based inhibitors of glutamate carboxypeptidase II: discovery of an orally active GCP II inhibitor.
Majer P; Jackson PF; Delahanty G; Grella BS; Ko YS; Li W; Liu Q; Maclin KM; Poláková J; Shaffer KA; Stoermer D; Vitharana D; Wang EY; Zakrzewski A; Rojas C; Slusher BS; Wozniak KM; Burak E; Limsakun T; Tsukamoto T
J Med Chem; 2003 May; 46(10):1989-96. PubMed ID: 12723961
[TBL] [Abstract][Full Text] [Related]
9. Cysteine derivatives as inhibitors for carboxypeptidase A: synthesis and structure-activity relationships.
Park JD; Kim DH
J Med Chem; 2002 Feb; 45(4):911-8. PubMed ID: 11831903
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic insight into the inactivation of carboxypeptidase A by alpha-benzyl-2-oxo-1,3-oxazolidine-4-acetic acid, a novel type of irreversible inhibitor for carboxypeptidase A with no stereospecificity.
Chung SJ; Chung S; Lee HS; Kim EJ; Oh KS; Choi HS; Kim KS; Kim YJ; Hahn JH; Kim DH
J Org Chem; 2001 Sep; 66(19):6462-71. PubMed ID: 11559199
[TBL] [Abstract][Full Text] [Related]
11. N-(Hydroxyaminocarbonyl)phenylalanine: a novel class of inhibitor for carboxypeptidase A.
Chung SJ; Kim DH
Bioorg Med Chem; 2001 Jan; 9(1):185-9. PubMed ID: 11197339
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and bioevaluation of 2-mercapto-6-phenylpyrimidine-4-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
Shi A; Zhang L; Wang H; Wang S; Yang M; Guan Q; Bao K; Zhang W
Eur J Med Chem; 2018 Jul; 155():590-595. PubMed ID: 29920453
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
Manning M; Lowbridge J; Sawyer WH; Haldar J
J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
[TBL] [Abstract][Full Text] [Related]
14. Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases.
Park JD; Kim DH; Kim SJ; Woo JR; Ryu SE
J Med Chem; 2002 Nov; 45(24):5295-302. PubMed ID: 12431056
[TBL] [Abstract][Full Text] [Related]
15. A new inhibitor design strategy for carboxypeptidase A as exemplified by N-(2-chloroethyl)-N-methylphenylalanine.
Park JD; Lee KJ; Kim DH
Bioorg Med Chem; 2001 Feb; 9(2):237-43. PubMed ID: 11249116
[TBL] [Abstract][Full Text] [Related]
16. Thioxophosphoranyl aryl- and heteroaryloxiranes as the representants of a new class of metallocarboxypeptidase inhibitors.
Fernández D; Illa O; Avilés FX; Branchadell V; Vendrell J; Ortuño RM
Bioorg Med Chem; 2008 May; 16(9):4823-8. PubMed ID: 18396051
[TBL] [Abstract][Full Text] [Related]
17. Design of potent and specific inhibitors of carboxypeptidases A and B.
Ondetti MA; Condon ME; Reid J; Sabo EF; Cheung HS; Cushman DW
Biochemistry; 1979 Apr; 18(8):1427-30. PubMed ID: 427123
[TBL] [Abstract][Full Text] [Related]
18. A new type of carboxypeptidase A inhibitors designed using an imidazole as a zinc coordinating ligand.
Lee KJ; Joo KC; Kim EJ; Lee M; Kim DH
Bioorg Med Chem; 1997 Oct; 5(10):1989-98. PubMed ID: 9370042
[TBL] [Abstract][Full Text] [Related]
19. Sulfamide derivatives as transition state analogue inhibitors for carboxypeptidase A.
Park JD; Kim DH
Bioorg Med Chem; 2004 May; 12(9):2349-56. PubMed ID: 15080932
[TBL] [Abstract][Full Text] [Related]
20. Irreversible inhibition of zinc-containing protease by oxazolidinone derivatives. Novel inactivation chemistry.
Kim DH; Chung SJ; Kim EJ; Tian GR
Bioorg Med Chem Lett; 1998 Apr; 8(7):859-64. PubMed ID: 9871555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
